When an expansive curlicue of tissue sitting below the ovaries was discovered more than a century ago, it was dismissed as useless and erased from biology textbooks. Biologists now are taking a new ...
Recent research sought to determine which patients with HR-positive breast cancer can benefit by adding ovarian function suppression to their adjuvant regimens, and which patients can skip it. A tumor ...
Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...
Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...
An ultrasound image of a human ovary that used shear wave elastography to assess ovarian stiffness by detecting and measuring fibrotic tissue. Medication to reduce ovarian scarring helps extends ...
A new blood test could help diagnose cancer cases earlier. Researchers from the University of Southern California (USC) developed a blood test to detect early onset ovarian cancer. The test, called ...
A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback